Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease☆
The early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging biomarkers of mild cognitive impairment (MCI) and Alzheimer's disease (AD) have been extensively explored using [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) and structural magnetic reson...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Elsevier
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791277/ |